SYRE
Price
$16.85
Change
+$0.28 (+1.69%)
Updated
Jun 4, 04:41 PM (EDT)
Capitalization
1B
57 days until earnings call
TRML
Price
$18.68
Change
+$0.24 (+1.30%)
Updated
Jun 4, 04:42 PM (EDT)
Capitalization
473.7M
Interact to see
Advertisement

SYRE vs TRML

Header iconSYRE vs TRML Comparison
Open Charts SYRE vs TRMLBanner chart's image
Spyre Therapeutics
Price$16.85
Change+$0.28 (+1.69%)
Volume$100
Capitalization1B
Tourmaline Bio
Price$18.68
Change+$0.24 (+1.30%)
Volume$200
Capitalization473.7M
SYRE vs TRML Comparison Chart
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. TRML commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Buy and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (SYRE: $16.57 vs. TRML: $18.44)
Brand notoriety: SYRE and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 77% vs. TRML: 133%
Market capitalization -- SYRE: $1B vs. TRML: $473.7M
SYRE [@Biotechnology] is valued at $1B. TRML’s [@Biotechnology] market capitalization is $473.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 4 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • SYRE’s TA Score: 4 bullish, 3 bearish.
  • TRML’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than TRML.

Price Growth

SYRE (@Biotechnology) experienced а +10.54% price change this week, while TRML (@Biotechnology) price change was +19.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.26%. For the same industry, the average monthly price growth was +5.04%, and the average quarterly price growth was -2.58%.

Reported Earning Dates

SYRE is expected to report earnings on Jul 31, 2025.

TRML is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+6.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1B) has a higher market cap than TRML($474M). TRML YTD gains are higher at: -9.073 vs. SYRE (-28.823). TRML has higher annual earnings (EBITDA): -98.41M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. TRML (249M). SYRE has less debt than TRML: SYRE (0) vs TRML (196K). SYRE (0) and TRML (0) have equivalent revenues.
SYRETRMLSYRE / TRML
Capitalization1B474M211%
EBITDA-214.36M-98.41M218%
Gain YTD-28.823-9.073318%
P/E Ratio1.72N/A-
Revenue00-
Total Cash565M249M227%
Total Debt0196K-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYRETRML
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITYAX60.43N/A
N/A
Invesco Technology A
PROVX19.08N/A
N/A
Provident Trust Strategy
FEMMX39.84N/A
N/A
Fidelity Advisor Emerging Markets C
MRLVX28.08N/A
N/A
BlackRock Advantage Large Cap Val R
FSEWX13.05N/A
N/A
Fidelity Sustainable U.S. Eq Z

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+7.60%
BEAM - SYRE
58%
Loosely correlated
+4.26%
CGON - SYRE
57%
Loosely correlated
+0.75%
IMNM - SYRE
53%
Loosely correlated
+2.21%
APGE - SYRE
53%
Loosely correlated
+2.06%
XNCR - SYRE
53%
Loosely correlated
+6.53%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+7.77%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
52%
Loosely correlated
+2.21%
STOK - TRML
46%
Loosely correlated
+9.99%
SYRE - TRML
46%
Loosely correlated
+7.60%
IPSC - TRML
45%
Loosely correlated
+4.89%
More